PDA/FDA 2026 session maps the GMP audit lifecycle, root cause to CAPA closure, plus a local vs. above-site decision framework and two case studies.
|Articles|March 2, 2017
- Pharmaceutical Technology-03-02-2017
- Volume 41
- Issue 3
Tabletop Pill Counter Automatically Counts and Fills Solid Oral-Dose Products
The Pharmafill TC4 Tabletop electronic tablet counter from Deitz Co. automatically counts pills, tablets, capsules, softgels, caplets, lozenges, and other solid oral-dose products and fills them into bottles.
The Pharmafill TC4 Tabletop electronic tablet counter from Deitz Co. automatically counts pills, tablets, capsules, softgels, caplets, lozenges, and other solid oral-dose products and fills them into bottles. The Pharmafill TC4 counts translucent, transparent, and opaque solid oral-dose products at up to 2000 per minute. The Tabletop TC4 is a computer-controlled operation, and measures 34 inches across, 21 inches deep, and 30 inches in height. The TC4 entry level counter includes an air guide system that automatically separates and aligns the pills on a single layer, a vibratory hopper feeder that automatically regulates the flow of tablets into the counter, and an optional smart bottle sensing system that automatically stops operation in the event of a problem with the bottle.
Articles in this issue
over 9 years ago
Understanding Containmentover 9 years ago
International Trade Issues Threaten Global Pharma Operationsover 9 years ago
Oral Delivery of Biologic APIs: The Challenge Continuesover 9 years ago
Covering Global Regulations in a Quality Systemover 9 years ago
Risk-Based Predictive Stability–An Industry Perspectiveover 9 years ago
Quality Agreements:Managing Global Relationshipsover 9 years ago
Achieving Manufacturing Excellenceover 9 years ago
Loading Bench for Cold-Chain Managementover 9 years ago
Mixers for Blending ApplicationsRelated to this article
The recently opened NJ spray drying facility doubles capacity for amorphous solid dispersions, addressing solubility limits in roughly 70% of small-molecule pipelines.
Lori Dingledine, QC Director Microbiological Control and GTIC Operations at Genentech, provided input on the regulations surrounding raw material manufacturing and use for ATMPs in a presentation at the 2026 PDA/FDA Joint Regulatory Conference.
FDA opens applications for its Expedited IND Pilot, pairing sponsors with qualified research institutions to test rolling CMC review ahead of first-in-human trials.
2026 approvals, clinical data, and licensing deals are advancing subcutaneous biologics, reducing patient burden, and reshaping biopharma drug strategy.
Karthik Iyer, Eli Lilly, details an AI system linking GMP findings, audits, and deviations for cited, inspection-ready regulatory intelligence.
At the PDA/FDA Joint Regulatory Conference 2026, Helen Motamen, MS
global head, Sanofi Quality Audit, Inspection, Intelligence & Advocacy, at Sanofi, provided advice for creating a strong internal audit program.
At PDA/FDA Joint Regulatory Conference 2026, PCI Pharma's Bassler details how a QMS overhaul turned an FDA 483 into stronger quality culture.
Trending on Pharmaceutical Technology
1
Driving Quality Culture to Manage Risk: Lessons from an FDA Inspection Response
2
FDA's IND Pilot Puts CMC Review First
3
Mature Medicines Divestment Signals Shift in Manufacturing Strategy
4
Spray Drying Capacity Signals Faster Paths for Poorly Soluble Drugs
5